Vaccines Medical Journal Abstracts
Advert for Healthcare Professionals only
Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives
Tropical Medcine and International Health
Nov 2012
Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives
The epidemiology of bacterial meningitis will change with introduction of meningococcal and pneumococcal conjugate vaccines in the African meningitis belt. The principal objectives of surveillance are to evaluate the impact of vaccination, to detect and investigate epidemics and provide material for research. The..Adult vaccination in 11 Central European countries – Calendars are not just for children
Vaccine
Jan 2012
Adult vaccination in 11 Central European countries – Calendars are not just for children
As Europe's population ages, disease morbidity and treatment costs in the adult population are likely to rise substantially, making this a pertinent time to review and revise preventive strategies such as vaccination. Vaccine uptake remains a problem for adults and there is a lack of coordinated programmes for..Medicaid reimbursement and the uptake of adolescent vaccines
Vaccine
Jan 2012
Medicaid reimbursement and the uptake of adolescent vaccines
Background: In light of low adolescent vaccination rates, state-level policies that could improve vaccine coverage should be evaluated. Approximately 1/3 of adolescents are eligible, primarily through medicaid enrollment, to receive vaccines from state-administered Vaccines for Children (VFC) programs. We investigated..Orf virus DNA vaccines expressing ORFV 011 and ORFV 059 chimeric protein enhances immunogenicity
Virology Journal
Dec 2011
Orf virus DNA vaccines expressing ORFV 011 and ORFV 059 chimeric protein enhances immunogenicity
Background: ORFV attenuated live vaccines have been the main prophylactic measure against contagious ecthyma in sheep and goats in the last decades, which play an important role in preventing the outbreak of the disease. However, the available vaccines do not induce lasting immunity in sheep and goats. On the other..Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine
Vaccine
Nov 2011
Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine
The investigational multicomponent meningococcus serogroup B vaccine (4CMenB) targets the antigenetically variable population of serogroup B meningococci. Forty-one strains of capsule null locus (cnl) meningococci, which are frequent among healthy carriers, were selected from nine sequence types (ST), which belong to..A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix® in subjects aged 11–17 years: An open, randomised, controlled trial
Vaccine
Nov 2011
A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix® in subjects aged 11–17 years: An open, randomised, controlled trial
The co-administration of the tetravalent meningococcal conjugate vaccine, MenACWY-TT, with a licensed hepatitis A and B vaccine, HepA/B (Twinrix®), was compared to their separate administration in this open, randomised, controlled study. Healthy subjects 11–17 years of age (n = 611) were randomised (3:1:1) to receive..How to manage vaccinations in children with cancer
Pediatric Blood & Cancer
Sep 2011
How to manage vaccinations in children with cancer
The optimal use of routine childhood immunizations in children with malignancy is still a matter of debate. Despite their higher risk of contracting vaccine preventable diseases and of suffering important complications, there is little understanding of the magnitude of the possible benefit of administering active..Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experience
Philosophical Transactions B
Sep 2011
Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experience
Adoption of new vaccines in developing countries is critical to reducing child mortality and meeting Millennium Development Goal 4. However, such introduction has historically suffered from significant delays that can be attributed to various factors including (i) lack of recognition of the value of a vaccine, (ii)..Comparison of protective immune responses to apicomplexan parasites.
Journal of parasitology research
Aug 2011
Comparison of protective immune responses to apicomplexan parasites.
Members of the phylum Apicomplexa, which includes the species Plasmodium, Eimeria, Toxoplasma, and Babesia amongst others, are the most successful intracellular pathogens known to humankind. The widespread acquisition of antimicrobial resistance to most drugs used to date has sparked a great deal of research and..EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
Annals of the Rheumatic Diseases
Aug 2011
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
Evidence-based recommendations for vaccination of paediatric patients with rheumatic diseases (PaedRD) were developed by following the EULAR standardised procedures for guideline development. The EULAR task force consisted of (paediatric) rheumatologists/immunologists, one expert in vaccine evaluation, one expert in..
Advert for Healthcare Professionals only